UNSPSC 51392206: Metizoline

This classification denotes an imidazole with the molecular formula C13H14N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z27L8N105U, chemically known as 1h-imidazole, 4,5-dihydro-2-((2-methylbenzo(b)thien-3-yl)methyl)- but generally known as metizoline, which bears US NIH Compound Identifier 28688. European Medicines Agency schedules Metizoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08898MIG.

UNSPSC 51392206 Metizoline is a Commodity code with minimal recent state and local procurement activity explicitly tagged to it. The two opportunities posted under this code in the source window do not represent purchases of metizoline itself but rather naloxone (an opioid antagonist), safe drug deactivation systems, and prescription fulfillment program design — none of which are metizoline. Metizoline is a nasal decongestant, and the tagging appears to reflect a data classification error rather than genuine procurement demand for the product. State and local buyers do not appear to be actively soliciting metizoline under this code at present.

The mismatch between the code name and the actual work being bought — opioid response and pharmacy benefit management rather than a single pharmaceutical ingredient — suggests the code either sees minimal use in state and local procurement or that agencies tagging these opportunities have applied the wrong classification. Without recent, correctly tagged solicitations for metizoline itself, no reliable characterization of issuing-body mix, geographic concentration, or market activity is supported by the source.